Health
UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients – News-Medical.Net
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Reviewed by Emily Henderson, B.Sc.Nov 18 2020
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Blood clots are one of the leading complications of COVID-19. Patients with COVID-19 often form blood clots throughout their bodies, which, if untreated, can lead to organ damage, including stroke, pulmonary embolism and heart attacks. We need to stop blood clot formation in order to prevent these potentially fatal complications…
-
General24 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
Noosa News23 hours agoLord mayor promises to review medium density planning laws
-
General16 hours agoThree maps that show the scale of the NSW flood disaster
-
Business23 hours agoWhere could the RBA interest rate go in the next 12 months?